UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

The Journal of neuroscience, 2002-10, Vol.22 (20), p.9099-9103

2002

Link zum Volltext

Verfügbarkeit prüfen

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

Movement disorders, 2005-08, Vol.20 (8), p.932-936

2005

Link zum Volltext

Verfügbarkeit prüfen

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity

Journal of clinical and experimental neuropsychology, 1998-06, Vol.20 (3), p.310-319

1998

Link zum Volltext

Verfügbarkeit prüfen

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Neurology, 2001-11, Vol.57 (10), p.1829

2001

Link zum Volltext

Verfügbarkeit prüfen

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Movement disorders, 2001-05, Vol.16 (3), p.515-520

2001

Link zum Volltext

Verfügbarkeit prüfen

Quetiapine Attenuates Levodopa-Induced Motor Complications in Rodent and Primate Parkinsonian Models

Experimental neurology, 2002-10, Vol.177 (2), p.557-564

2002

Link zum Volltext

Verfügbarkeit prüfen

Glutamate release inhibition ineffective in Levodopa-induced motor complications

Movement disorders, 2006-09, Vol.21 (9), p.1380-1383

2006

Link zum Volltext

Verfügbarkeit prüfen

Distinct Pathological Features of the Gallyas- and Tau-positive Glia in the Parkinsonism-Dementia Complex and Amyotrophic Lateral Sclerosis of Guam

Journal of neuropathology and experimental neurology, 1997-03, Vol.56 (3), p.308-316

1997

Link zum Volltext

Verfügbarkeit prüfen

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

Movement disorders, 2004-10, Vol.19 (10), p.1183-1186

2004

Link zum Volltext

Verfügbarkeit prüfen

Continuous transdermal dopaminergic stimulation in advanced Parkinson's Disease

Clinical neuropharmacology, 2001-05, Vol.24 (3), p.163-169

2001

Link zum Volltext

Verfügbarkeit prüfen

A trial of dextromethorphan in parkinsonian patients with motor response complications

Movement disorders, 1998-05, Vol.13 (3), p.414-417

1998

Link zum Volltext

Verfügbarkeit prüfen

Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study

Archives of neurology (Chicago), 1999-11, Vol.56 (11), p.1383

1999

Link zum Volltext

Verfügbarkeit prüfen

Complications of a trophic xenotransplant approach in parkinsonian monkeys

Progress in neuro-psychopharmacology & biological psychiatry, 2003-06, Vol.27 (4), p.607-612

2003

Link zum Volltext

Verfügbarkeit prüfen

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Neurology, 1998-05, Vol.50 (5), p.1323

1998

Link zum Volltext

Verfügbarkeit prüfen

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

Annals of neurology, 1996-05, Vol.39 (5), p.574-578

1996

Link zum Volltext

Verfügbarkeit prüfen

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease

Drugs (Basel), 1998, Vol.55, p.1-9

CHASE, T. N

1998

Link zum Volltext

Verfügbarkeit prüfen

Cortical abnormalities in Alzheimer's disease

Annals of neurology, 1984-12, Vol.16 (6), p.649-654

1984

Link zum Volltext

Verfügbarkeit prüfen

Towards a behavioral typology of Alzheimer's patients

Journal of clinical and experimental neuropsychology, 1986-10, Vol.8 (5), p.594-610

1986

Link zum Volltext

Verfügbarkeit prüfen

Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons

Neuroscience letters, 1984-12, Vol.52 (3), p.213-217

1984

Link zum Volltext

Verfügbarkeit prüfen

Implicit memory in alzheimer's disease

Journal of clinical and experimental neuropsychology, 1995-06, Vol.17 (3), p.343-351

1995

Link zum Volltext

Verfügbarkeit prüfen

Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography

Annals of neurology, 1984, Vol.15 (S1), p.170-174

1984

Link zum Volltext

Verfügbarkeit prüfen

Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome

Archives of general psychiatry, 1992-07, Vol.49 (7), p.522

1992

Link zum Volltext

Verfügbarkeit prüfen

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

Annals of neurology, 1990-01, Vol.27 (1), p.18-23

1990

Link zum Volltext

Verfügbarkeit prüfen

Personality variables, neurological and psychopathological symptoms in patients suffering from spasmodic torticollis

Comprehensive psychiatry, 1988-03, Vol.29 (2), p.182-187

1988

Link zum Volltext

Verfügbarkeit prüfen

Peripheral beta-adrenergic blockade treatment of parkinsonian tremor

Annals of neurology, 1984-10, Vol.16 (4), p.505-508

1984

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 120

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(120)

Sprache

Englisch
(120)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(112)
Life Sciences & Biomedicine
(111)
Humans
(109)
Male
(106)
Middle Aged
(80)
Neurosciences & Neurology
(79)
Clinical Neurology
(69)
Aged
(61)
Biological And Medical Sciences
(56)
Adult
(55)
Medical Sciences
(53)
Parkinson Disease - Drug Therapy
(35)
Pharmacology. Drug Treatments
(27)
Neurology
(25)
Neuropharmacology
(23)
Double-Blind Method
(20)
Neurosciences
(19)
Animals
(16)
Hydroxyindoleacetic Acid - Cerebrospinal Fluid
(16)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Quetiapine Attenuates Levodopa-Induced Motor Complications in Rodent and Primate Parkinsonian Models

Glutamate release inhibition ineffective in Levodopa-induced motor complications

Distinct Pathological Features of the Gallyas- and Tau-positive Glia in the Parkinsonism-Dementia Complex and Amyotrophic Lateral Sclerosis of Guam

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

Continuous transdermal dopaminergic stimulation in advanced Parkinson's Disease

A trial of dextromethorphan in parkinsonian patients with motor response complications

Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study

Complications of a trophic xenotransplant approach in parkinsonian monkeys

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease

Cortical abnormalities in Alzheimer's disease

Towards a behavioral typology of Alzheimer's patients

Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons

Implicit memory in alzheimer's disease

Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography

Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

Personality variables, neurological and psychopathological symptoms in patients suffering from spasmodic torticollis

Peripheral beta-adrenergic blockade treatment of parkinsonian tremor

Aktive Filter

Suchergebnisse filtern